NovaBridge Biosciences
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -51.2% | -51.2% | -41.6% |
| FY2022 | -88.8% | -88.8% | -62.8% |
| FY2023 | -85.6% | -85.6% | -56.3% |
| FY2024 | -11.1% | -11.1% | -10.5% |
| FY2025 | -20.0% | -20.0% | -17.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -51.2% | -51.2% | -41.6% |
| FY2022 | -88.8% | -88.8% | -62.8% |
| FY2023 | -85.6% | -85.6% | -56.3% |
| FY2024 | -11.1% | -11.1% | -10.5% |
| FY2025 | -20.0% | -20.0% | -17.8% |